214 related articles for article (PubMed ID: 33980826)
1. Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis.
Dika E; Broseghini E; Porcellini E; Lambertini M; Riefolo M; Durante G; Loher P; Roncarati R; Bassi C; Misciali C; Negrini M; Rigoutsos I; Londin E; Patrizi A; Ferracin M
Cell Death Dis; 2021 May; 12(5):473. PubMed ID: 33980826
[TBL] [Abstract][Full Text] [Related]
2. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
3. [Molecular networks and mechanisms of epithelial-mesenchymal transition regulated by miRNAs in the malignant melanoma cell line].
Wang D; Li YJ; Ding N; Wang JY; Yang Q; Yang YR; Li YM; Fang XD; Zhao H
Yi Chuan; 2015 Jul; 37(7):673-82. PubMed ID: 26351167
[TBL] [Abstract][Full Text] [Related]
4. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.
Murria Estal R; de Unamuno Bustos B; Pérez Simó G; Simarro Farinos J; Torres Navarro I; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
Melanoma Res; 2021 Feb; 31(1):18-26. PubMed ID: 33234848
[TBL] [Abstract][Full Text] [Related]
7. In-depth characterization of microRNA transcriptome in melanoma.
Kozubek J; Ma Z; Fleming E; Duggan T; Wu R; Shin DG; Dadras SS
PLoS One; 2013; 8(9):e72699. PubMed ID: 24023765
[TBL] [Abstract][Full Text] [Related]
8. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
[TBL] [Abstract][Full Text] [Related]
9. Novel MicroRNA Biomarkers,
Xu Y; Wang L; Jiang L; Zhang X
J Comput Biol; 2020 May; 27(5):815-824. PubMed ID: 31526187
[TBL] [Abstract][Full Text] [Related]
10. A preliminary study of microRNA expression in different types of primary melanoma.
Gencia I; Baderca F; Avram S; Gogulescu A; Marcu A; Seclaman E; Marian C; Solovan C
Bosn J Basic Med Sci; 2020 May; 20(2):197-208. PubMed ID: 31479413
[TBL] [Abstract][Full Text] [Related]
11. Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma.
Dika E; Riefolo M; Porcellini E; Broseghini E; Ribero S; Senetta R; Osella-Abate S; Scarfì F; Lambertini M; Veronesi G; Patrizi A; Fanti PA; Ferracin M
J Invest Dermatol; 2020 Nov; 140(11):2260-2267. PubMed ID: 32275975
[TBL] [Abstract][Full Text] [Related]
12. Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model.
Antonova E; Hambikova A; Shcherbakov D; Sukhov V; Vysochanskaya S; Fadeeva I; Gorshenin D; Sidorova E; Kashutina M; Zhdanova A; Mitrokhin O; Avvakumova N; Zhernov Y
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298110
[TBL] [Abstract][Full Text] [Related]
13. Selected isomiR expression profiles via arm switching?
Guo L; Zhang H; Zhao Y; Yang S; Chen F
Gene; 2014 Jan; 533(1):149-55. PubMed ID: 24120620
[TBL] [Abstract][Full Text] [Related]
14. Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.
Babapoor S; Wu R; Kozubek J; Auidi D; Grant-Kels JM; Dadras SS
Lab Invest; 2017 Jun; 97(6):636-648. PubMed ID: 28218741
[TBL] [Abstract][Full Text] [Related]
15. Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.
DiVincenzo MJ; Angell CD; Suarez-Kelly LP; Ren C; Barricklow Z; Moufawad M; Fadda P; Yu L; Backes FJ; Ring K; Mills A; Slingluff C; Chung C; Gru AA; Carson WE
PLoS One; 2023; 18(6):e0285804. PubMed ID: 37384650
[TBL] [Abstract][Full Text] [Related]
16. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
17. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi.
Prodan M; Costescu S; Elagez A; Laitin SMD; Bloanca V; Crainiceanu Z; Seclaman E; Toma AO; Fericean RM; Puenea G; Cozma GV
Curr Oncol; 2024 May; 31(5):2881-2894. PubMed ID: 38785501
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM
Front Oncol; 2020; 10():756. PubMed ID: 32509578
[TBL] [Abstract][Full Text] [Related]
19. Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma.
DiVincenzo MJ; Schwarz E; Ren C; Barricklow Z; Moufawad M; Yu L; Fadda P; Angell C; Sun S; Howard JH; Chung C; Slingluff C; Gru AA; Kendra K; Carson WE
J Invest Dermatol; 2023 Apr; 143(4):630-638.e3. PubMed ID: 36202232
[TBL] [Abstract][Full Text] [Related]
20. Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma.
Polini B; Carpi S; Doccini S; Citi V; Martelli A; Feola S; Santorelli FM; Cerullo V; Romanini A; Nieri P
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
